IDO1 Inhibitor RY103 Suppresses Trp-GCN2-Mediated Angiogenesis and Counters Immunosuppression in Glioblastoma

IDO1 Inhibitor RY103 Suppresses Trp-GCN2-Mediated Angiogenesis and Counters Immunosuppression in Glioblastoma

Glioma is characterized by strong immunosuppression and excessive angiogenesis. Based on existing reports, it can be speculated that the resistance to anti-angiogenic drug vascular endothelial growth factor A (VEGFA) antibody correlates to the induction of novel immune checkpoint indoleamine 2,3-dio...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Zikang Xing, Xuewen Li, Zhen Ning Tony He, Xin Fang, Heng Liang, Chunxiang Kuang, Aiying Li, Qing Yang
स्वरूप:	लेख
भाषा:	English
प्रकाशित:	MDPI AG 2024-06-01
श्रृंखला:	Pharmaceutics
विषय:	glioma angiogenesis indoleamine 2,3-dioxygenase 1 tryptophan depletion general control nonderepressible 2
ऑनलाइन पहुंच:	https://www.mdpi.com/1999-4923/16/7/870

समान संसाधन

TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
द्वारा: V. A. Kozlov, और अन्य
प्रकाशित: (2017-07-01)

On the nonredundant roles of TDO2 and IDO1
द्वारा: Paolo ePuccetti
प्रकाशित: (2014-10-01)

Activities of plasma indoleamine-2, 3-dioxygenase (IDO) enzyme in Nigerian patients with lung diseases: basis for tryptophan supplementation or IDO inhibitor use
द्वारा: Ganiyu Olatunbosun Arinola, और अन्य
प्रकाशित: (2023-01-01)

The Two Sides of Indoleamine 2,3-Dioxygenase 2 (IDO2)
द्वारा: Chiara Suvieri, और अन्य
प्रकाशित: (2024-11-01)

What is the prospect of indoleamine 2,3-dioxygenase 1 inhibition in cancer? Extrapolation from the past
द्वारा: Yu Yao, और अन्य
प्रकाशित: (2021-02-01)

Tryptophan-degrading enzymes in tumoral immune resistance
द्वारा: Nicolas van Baren, और अन्य
प्रकाशित: (2016-11-01)

Association of Indoleamine 2,3-Dioxygenase (IDO) Activity with Outcome after Cardiac Surgery in Adult Patients
द्वारा: Andrea Stieger, और अन्य
प्रकाशित: (2024-06-01)

Targeting Indoleamine Dioxygenase and Tryptophan Dioxygenase in Cancer Immunotherapy: Clinical Progress and Challenges
द्वारा: Peng X, और अन्य
प्रकाशित: (2022-08-01)

Serum neopterin concentrations and tryptophan degradation pattern in patients with late stage larynx carcinoma
द्वारा: Engin Ayse Basak, और अन्य
प्रकाशित: (2017-08-01)

Indoleamine 2,3-dioxygenase (IDO): Only an enzyme or a checkpoint controller?
द्वारा: Cemil Bilir, M.D., और अन्य
प्रकाशित: (2017-07-01)

Kynurenines as a Novel Target for the Treatment of Inflammatory Disorders
द्वारा: Adrian Mor, और अन्य
प्रकाशित: (2024-07-01)

The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1
द्वारा: Eleonora Panfili, और अन्य
प्रकाशित: (2023-04-01)

Design, Synthesis and Biological Evaluation of Phenyl Urea Derivatives as IDO1 Inhibitors
द्वारा: Chuan Zhou, और अन्य
प्रकाशित: (2020-03-01)

Tumor Microenvironment‐Responsive Nanoparticles Enhance IDO1 Blockade Immunotherapy by Remodeling Metabolic Immunosuppression
द्वारा: Mengna Wang, और अन्य
प्रकाशित: (2025-02-01)

Pharmacological Targets of Kaempferol Within Inflammatory Pathways—A Hint Towards the Central Role of Tryptophan Metabolism
द्वारा: Stefanie Hofer, और अन्य
प्रकाशित: (2020-02-01)

Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives
द्वारा: Florent Peyraud, और अन्य
प्रकाशित: (2022-01-01)

The Potential Role of Cannabinoids in Modulating Serotonergic Signaling by Their Influence on Tryptophan Metabolism
द्वारा: Dietmar Fuchs, और अन्य
प्रकाशित: (2010-08-01)

Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia
द्वारा: Christine L Miller, और अन्य
प्रकाशित: (2004-04-01)

In vitro Effects of Nigella sativa Seeds Extracts on Stimulated Peripheral Blood Mononuclear Cells
द्वारा: Winkler Christiana, और अन्य
प्रकाशित: (2008-02-01)

The Coevolution of IDO1 and AhR in the Emergence of Regulatory T Cells in Mammals
द्वारा: Ursula eGrohmann, और अन्य
प्रकाशित: (2015-02-01)

Systemic tryptophan homeostasis
द्वारा: Simon Klaessens, और अन्य
प्रकाशित: (2022-09-01)

DSS-induced colitis activates the kynurenine pathway in serum and brain by affecting IDO-1 and gut microbiota
द्वारा: Li-Ping Zhao, और अन्य
प्रकाशित: (2023-01-01)

1-MT inhibits the invasion of CBP-resistant ovarian cancer cells via down-regulating IDO expression and re-activating immune cells function
द्वारा: Huihan Ma, और अन्य
प्रकाशित: (2020-09-01)

Increased Indoleamine 2,3-Dioxygenase 1 (IDO-1) Activity and Inflammatory Responses during Chikungunya Virus Infection
द्वारा: Thiara Manuele Alves de Souza, और अन्य
प्रकाशित: (2022-04-01)

Indoleamine 2,3-Dioxygenase as a Therapeutic Target for Alzheimer’s Disease and Geriatric Depression
द्वारा: Karl Savonije, और अन्य
प्रकाशित: (2023-05-01)

An exploratory study of neopterin and kynurenine pathway in pterygium
द्वारा: Kilicarslan Bilge, और अन्य
प्रकाशित: (2019-08-01)

Indoleamine 2,3-Dioxygenase Expression Pattern in the Tumor Microenvironment Predicts Clinical Outcome in Early Stage Cervical Cancer
द्वारा: A. Marijne Heeren, और अन्य
प्रकाशित: (2018-07-01)

Nattokinase mitigated dextran sulfate sodium-induced chronic colitis by regulating microbiota and suppressing tryptophan metabolism via inhibiting IDO-1
द्वारा: Lvqi Zhou, और अन्य
प्रकाशित: (2020-12-01)

Deletion of indoleamine 2,3 dioxygenase (Ido)1 but not Ido2 exacerbates disease symptoms of MOG35-55-induced experimental autoimmune encephalomyelitis
द्वारा: Lisa A. Wetzel, और अन्य
प्रकाशित: (2020-08-01)

IDO Inhibitor and Gallic Acid Cross-Linked Small Molecule Drug Synergistic Treatment of Melanoma
द्वारा: Hongmei Liu, और अन्य
प्रकाशित: (2022-07-01)

Targeting the IDO1 pathway in cancer: from bench to bedside
द्वारा: Ming Liu, और अन्य
प्रकाशित: (2018-08-01)

Tryptophan catabolism increases in breast cancer patients compared to healthy controls without affecting the cancer outcome or response to chemotherapy
द्वारा: Concetta Elisa Onesti, और अन्य
प्रकाशित: (2019-07-01)

Biological and clinical significance of tryptophan-catabolizing enzymes in cutaneous T-cell lymphomas
द्वारा: Pilvi Maliniemi, और अन्य
प्रकाशित: (2017-03-01)

Combination of IDO inhibitors and platinum(IV) prodrugs reverses low immune responses to enhance cancer chemotherapy and immunotherapy for osteosarcoma
द्वारा: Dongquan Xiang, और अन्य
प्रकाशित: (2023-06-01)

Kynurenines as a Novel Target for the Treatment of Malignancies
द्वारा: Adrian Mor, और अन्य
प्रकाशित: (2021-06-01)

The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity
द्वारा: Jacques C. Mbongue, और अन्य
प्रकाशित: (2015-09-01)

The role of tryptophan in Chlamydia trachomatis persistence
द्वारा: Li Wang, और अन्य
प्रकाशित: (2022-08-01)

Design and Synthesis of Indoleamine 2,3-Dioxygenase 1 Inhibitors and Evaluation of Their Use as Anti-Tumor Agents
द्वारा: Hui Wen, और अन्य
प्रकाशित: (2019-06-01)

AncPhore: A versatile tool for anchor pharmacophore steered drug discovery with applications in discovery of new inhibitors targeting metallo-β-lactamases and indoleamine/tryptophan 2,3-dioxygenases
द्वारा: Qingqing Dai, और अन्य
प्रकाशित: (2021-07-01)

Tryptophan Breakdown in Patients with HCV Infection is Influenced by IL28B Polymorphism
द्वारा: Heinz Zoller, और अन्य
प्रकाशित: (2015-06-01)